Michael F. Cola
Mr. Michael F. Cola is a Chief Executive Officer & Director at Cerecor, Inc., an Independent Director at Phathom Pharmaceuticals, Inc., an Independent Director at SAGE Therapeutics, Inc. and a Chairman-Governors Board at The Boys & Girls Clubs of Philadelphia. He is on the Board of Directors at Cerecor, Inc., Phathom Pharmaceuticals, Inc., SAGE Therapeutics, Inc., Life Sciences Pennsylvania and Ursinus College. Mr. Cola was previously employed as a President, Chief Executive Officer & Director by Aevi Genomic Medicine, Inc., an Independent Director by Vanda Pharmaceuticals, Inc., an Independent Director by NuPathe, Inc., an Executive Vice President-Therapeutic Area Business by Shire Plc /Old/, a President-Specialty Pharmaceuticals by Shire Plc, a Chairman by Spherion Corp., a Chairman by Clarient, Inc., a President-Life Sciences Group by Safeguard Scientifics, Inc., a Vice President-Global Clinical Operations by AstraZeneca Plc, a Vice President-Global Clinical Operations by Astra Merck, Inc., and a Chairman by Laureate Biopharmaceutical Services, Inc. He received his undergraduate degree from Ursinus College and a graduate degree from Drexel University.
|02/03/2020||75,746||Award at $0 per share.||0|